1
|
Nimje RY, Vytla D, Kuppusamy P, Velayuthaperumal R, Jarugu LB, Reddy CA, Chikkananjaiah NK, Rampulla RA, Cavallaro CL, Li J, Mathur A, Gupta A, Roy A. Synthesis of Differentially Protected Azatryptophan Analogs via Pd 2(dba) 3/XPhos Catalyzed Negishi Coupling of N-Ts Azaindole Halides with Zinc Derivative from Fmoc-Protected tert-Butyl ( R)-2-Amino-3-iodopropanoate. J Org Chem 2020; 85:11519-11530. [PMID: 32786620 DOI: 10.1021/acs.joc.0c00973] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Unnatural amino acids play an important role in peptide based drug discovery. Herein, we report a class of differentially protected azatryptophan derivatives synthesized from N-tosyl-3-haloazaindoles 1 and Fmoc-protected tert-butyl iodoalanine 2 via a Negishi coupling. Through ligand screening, Pd2(dba)3/XPhos was found to be a superior catalyst for the coupling of 1 with the zinc derivative of 2 to give tert-butyl (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(1-tosyl-1H-pyrrolo[2,3-b]pyridin-3-yl)propanoate derivatives 3 in 69-91% isolated yields. In addition, we have demonstrated that the protecting groups, namely, Ts, Fmoc, and tBu, can be easily removed selectively.
Collapse
Affiliation(s)
- Roshan Y Nimje
- Department of Discovery Synthesis, Biocon Bristol-Myers Squibb R&D Center, Syngene International Ltd., Biocon Park, Plot No. 2 and 3, Bommasandra-Jigani Road, Bangalore-560 100, India
| | - Devaiah Vytla
- Department of Discovery Synthesis, Biocon Bristol-Myers Squibb R&D Center, Syngene International Ltd., Biocon Park, Plot No. 2 and 3, Bommasandra-Jigani Road, Bangalore-560 100, India
| | - Prakasam Kuppusamy
- Department of Discovery Synthesis, Biocon Bristol-Myers Squibb R&D Center, Syngene International Ltd., Biocon Park, Plot No. 2 and 3, Bommasandra-Jigani Road, Bangalore-560 100, India
| | - Rajeswari Velayuthaperumal
- Department of Discovery Synthesis, Biocon Bristol-Myers Squibb R&D Center, Syngene International Ltd., Biocon Park, Plot No. 2 and 3, Bommasandra-Jigani Road, Bangalore-560 100, India
| | - Lokesh Babu Jarugu
- Department of Discovery Synthesis, Biocon Bristol-Myers Squibb R&D Center, Syngene International Ltd., Biocon Park, Plot No. 2 and 3, Bommasandra-Jigani Road, Bangalore-560 100, India
| | - China Anki Reddy
- Department of Discovery Synthesis, Biocon Bristol-Myers Squibb R&D Center, Syngene International Ltd., Biocon Park, Plot No. 2 and 3, Bommasandra-Jigani Road, Bangalore-560 100, India
| | - Nanjundaswamy Kanikahalli Chikkananjaiah
- Department of Discovery Synthesis, Biocon Bristol-Myers Squibb R&D Center, Syngene International Ltd., Biocon Park, Plot No. 2 and 3, Bommasandra-Jigani Road, Bangalore-560 100, India
| | - Richard A Rampulla
- Small Molecule Drug Discovery, Bristol-Myers Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08543-4000, United States
| | - Cullen L Cavallaro
- Small Molecule Drug Discovery, Bristol-Myers Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08543-4000, United States
| | - Jianqing Li
- Small Molecule Drug Discovery, Bristol-Myers Squibb Research and Development, 100 Binney Street, Cambridge, Massachusetts 02142, United States
| | - Arvind Mathur
- Small Molecule Drug Discovery, Bristol-Myers Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08543-4000, United States
| | - Anuradha Gupta
- Department of Discovery Synthesis, Biocon Bristol-Myers Squibb R&D Center, Syngene International Ltd., Biocon Park, Plot No. 2 and 3, Bommasandra-Jigani Road, Bangalore-560 100, India
| | - Amrita Roy
- Department of Discovery Synthesis, Biocon Bristol-Myers Squibb R&D Center, Syngene International Ltd., Biocon Park, Plot No. 2 and 3, Bommasandra-Jigani Road, Bangalore-560 100, India
| |
Collapse
|
2
|
Andreev S, Pantsar T, Ansideri F, Kudolo M, Forster M, Schollmeyer D, Laufer SA, Koch P. Design, Synthesis and Biological Evaluation of 7-Chloro-9 H-pyrimido[4,5- b]indole-based Glycogen Synthase Kinase-3β Inhibitors. Molecules 2019; 24:molecules24122331. [PMID: 31242571 PMCID: PMC6630214 DOI: 10.3390/molecules24122331] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2019] [Revised: 06/19/2019] [Accepted: 06/20/2019] [Indexed: 12/17/2022] Open
Abstract
Glycogen synthase kinase-3β (GSK-3β) represents a relevant drug target for the treatment of neurodegenerative pathologies including Alzheimer's disease. We herein report on the optimization of a novel class of GSK-3β inhibitors based on the tofacitinib-derived screen hit 3-((3R,4R)-3-((7-chloro-9H-pyrimido[4,5-b]indol-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile (1). We synthesized a series of 19 novel 7-chloro-9H-pyrimido[4,5-b]indole-based derivatives and studied their structure-activity relationships with focus on the cyanoacetyl piperidine moiety. We unveiled the crucial role of the nitrile group and its importance for the activity of this compound series. A successful rigidization approach afforded 3-(3aRS,7aSR)-(1-(7-chloro-9H-pyrimido[4,5-b]indol-4-yl)octahydro-6H-pyrrolo[2,3-c]pyridin-6-yl)-propanenitrile (24), which displayed an IC50 value of 130 nM on GSK-3β and was further characterized by its metabolic stability. Finally, we disclosed the putative binding modes of the most potent inhibitors within the ATP binding site of GSK-3β by 1 µs molecular dynamics simulations.
Collapse
Affiliation(s)
- Stanislav Andreev
- Institute of Pharmaceutical Sciences, Department of Medicinal and Pharmaceutical Chemistry, Eberhard Karls University Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, Germany.
| | - Tatu Pantsar
- Department of Internal Medicine VIII, University Hospital Tübingen, Otfried-Müller-Str. 14, 72076 Tübingen, Germany.
- School of Pharmacy, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland.
| | - Francesco Ansideri
- Institute of Pharmaceutical Sciences, Department of Medicinal and Pharmaceutical Chemistry, Eberhard Karls University Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, Germany.
| | - Mark Kudolo
- Institute of Pharmaceutical Sciences, Department of Medicinal and Pharmaceutical Chemistry, Eberhard Karls University Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, Germany.
| | - Michael Forster
- Institute of Pharmaceutical Sciences, Department of Medicinal and Pharmaceutical Chemistry, Eberhard Karls University Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, Germany.
| | - Dieter Schollmeyer
- Department of Organic Chemistry, Johannes Gutenberg University Mainz, Duesbergweg 10-14, 55099 Mainz, Germany.
| | - Stefan A Laufer
- Institute of Pharmaceutical Sciences, Department of Medicinal and Pharmaceutical Chemistry, Eberhard Karls University Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, Germany.
| | - Pierre Koch
- Institute of Pharmaceutical Sciences, Department of Medicinal and Pharmaceutical Chemistry, Eberhard Karls University Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, Germany.
- Department of Pharmaceutical/Medicinal Chemistry II, Institute of Pharmacy, University of Regensburg, Universitätsstraße 31, 93053 Regensburg, Germany.
| |
Collapse
|
3
|
Fan LL, Che ZP, Zhang R, Yu X, Zhi XY, Xu H. Synthesis of benzopyrano[4,3-b](N-arylsulfonyl)indoles and benzopyrano[3,4-b](N-arylsulfonyl)indoles via intramolecular palladium-catalyzed aryl-aryl coupling reaction. Mol Divers 2012; 16:415-21. [PMID: 22528272 DOI: 10.1007/s11030-012-9370-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/25/2011] [Accepted: 03/16/2012] [Indexed: 11/26/2022]
Abstract
A series of benzopyrano[3,4-b](N-arylsulfonyl) indole derivatives and benzopyrano[4,3-b](N-arylsulfonyl) indole derivatives were synthesized from 2- or 3-methylindole via intermolecular S( N )2 reaction and subsequent intramolecular palladium-catalyzed aryl-aryl coupling reaction for the first time. It was suggested that, besides using the Fischer cyclization, benzopyrano[4,3-b]indoles and benzopyrano[3,4-b]indoles could also be prepared via intermolecular S( N )2 reaction and sequential intramolecular palladium-catalyzed coupling reaction.
Collapse
Affiliation(s)
- Ling-Ling Fan
- College of Sciences, Northwest A&F University, Yangling, People's Republic of China
| | | | | | | | | | | |
Collapse
|
7
|
Fan LL, Liu WQ, Xu H, Yang LM, Lv M, Zheng YT. Anti Human Immunodeficiency Virus-1 (HIV-1) Agents 3. Synthesis and in Vitro Anti-HIV-1 Activity of Some N-Arylsulfonylindoles. Chem Pharm Bull (Tokyo) 2009; 57:797-800. [DOI: 10.1248/cpb.57.797] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Affiliation(s)
- Ling-Ling Fan
- Laboratory of Pharmaceutical Design & Synthesis, College of Sciences, Northwest A&F University
| | - Wu-Qing Liu
- Laboratory of Molecular Immunopharmacology, Key Laboratory of Animal Models and Human Diseases Mechanisms, Kunming Institute of Zoology, Chinese Academy of Sciences
- Graduate School of the Chinese Academy of Sciences
| | - Hui Xu
- Laboratory of Pharmaceutical Design & Synthesis, College of Sciences, Northwest A&F University
| | - Liu-Meng Yang
- Laboratory of Molecular Immunopharmacology, Key Laboratory of Animal Models and Human Diseases Mechanisms, Kunming Institute of Zoology, Chinese Academy of Sciences
| | - Min Lv
- Laboratory of Pharmaceutical Design & Synthesis, College of Sciences, Northwest A&F University
| | - Yong-Tang Zheng
- Laboratory of Molecular Immunopharmacology, Key Laboratory of Animal Models and Human Diseases Mechanisms, Kunming Institute of Zoology, Chinese Academy of Sciences
| |
Collapse
|